- Small biotech firm Novavax has made progress in its efforts to develop a novel vaccine to guard against coronavirus disease.
- Phase I clinical testing will be conducted in May or June.
- Several biotechs and other drugmakers desperately trying to come up with a vaccine to treat the epidemic.
The company announced in a press release that it has made pro....
Tags : stocks, vaccine, coronavirus, market,